Mammalian sphingomyelinases have been implicated in many important physiological and pathophysiological processes. Although several mammalian sphingomyelinases have been identified and studied, one of these, an acidic Zn 2؉ -stimulated sphingomyelinase (Zn-SMase) originally found in fetal bovine serum, has received little attention since its first and only report 7 years ago. We now show that Zn-SMase activity is secreted by human and murine macrophages, human skin fibroblasts, microglial cells, and several other cells in culture and is markedly up-regulated during differentiation of human monocytes to macrophages. Remarkably, peritoneal macrophages from mice in which the acid SMase gene had been disrupted by homologous recombination secreted no Zn-SMase activity, indicating that this enzyme and the intracellular lysosomal SMase, which is Zn-independent, arise from the same gene. Furthermore, skin fibroblasts from patients with types A and B NiemannPick disease, which are known to lack lysosomal SMase activity, also lack Zn-SMase activity in their conditioned media. Chinese hamster ovary cells stably transfected with a cDNA encoding lysosomal SMase massively overexpress both cellular lysosomal SMase and secreted ZnSMase activities. Thus, Zn-SMase arises independently of alternative splicing, suggesting a post-translational process. In summary, a wide variety of cell types secrete Zn-SMase activity, which arises from the same gene as lysosomal SMase. This secreted enzyme may play roles in physiological and pathophysiological processes involving extracellular sphingomyelin hydrolysis.
Mammalian SMases1 have been implicated in many important physiological and pathophysiological processes, including lysosomal digestion of sphingomyelin, which is important for normal neuronal and vascular function (1); ceramide-mediated signal transduction, leading to cytokine-induced apoptosis, cellular differentiation, and various immune and inflammatory responses (2, 3); lipoprotein aggregation within the vessel wall, which is a key event in atherogenesis (4 -7); and intracellular cholesterol trafficking and metabolism (8 -10).2 Several different forms of mammalian SMases have been identified, including: (a) a lysosomal SMase that is present in all tissues, acts optimally at low pH, and shows no dependence on divalent cations (11). This enzyme, which is defective in types A and B Niemann-Pick disease (11), has been purified and cloned (12), and mice in which the gene encoding lysosomal SMase has been inactivated have recently been generated (13, 14); (b) a neutral, membrane-associated, Mg 2ϩ -stimulated SMase that is found predominantly in brain and kidney (15) and that is known to arise from a separate gene from lysosomal SMase (16) Although the molecular identity and functions are definitively known only for lysosomal SMase (15), two of the other forms, namely, Mg 2ϩ -stimulated SMase and cytosolic SMase, also have been studied. Both have been partially purified (17,19,20), and these two enzymes, in addition to lysosomal SMase, ...